Sort   by:  
 Page size 
TranscriptomicsAdaptation of Sulfolobus solfataricus P2 to fluctuating O2 concentrations
Sulfolobus solfataricus P2 was grown aerobically, with O2 concentrations ranging from 1.5 to 26 % (v/v; gas phase). To gain some insight in control of the respiratory system, transcriptomes of the strain cultivated in different O2 concentrations (1.5 % vs 21 %, 1.5 % vs 26 %) were compared using a D...
ORGANISM(S): Sulfolobus solfataricus 
2010-05-18 | E-GEOD-16043 | biostudies-arrayexpress
UnknownUsing virtual twin-based AI models to detect atrial fibrillation and improve stroke outcomes [TAILOR]: a multicentre prospective cohort study.
Not available
S-EPMC12742137 | biostudies-literature
TranscriptomicsTranscriptome analysis of infection of the archaeon Sulfolobus solfataricus with STIV
Time series of infection of Sulfolobus solfataricus strain 2-2-12 cells infected with STIV are compared with uninfected cells over 32 h. Two-condition experiment, Control vs. Infected cells sampled at 5 time points (0, 8, 16, 24, 32 h post infection). Biological replicates: 3 control, 3 infected, pa...
ORGANISM(S): Sulfolobus solfataricus 
2008-07-25 | E-GEOD-12235 | biostudies-arrayexpress
TranscriptomicsTranscriptional analysis of the response of Caldicellulosiruptor saccharolyticus to different H2 partial pressures
Caldicellulosiruptor saccharolyticus is an extremely thermophilic, gram-positive anaerobe which ferments a broad range of substrates to mainly acetate, CO2, and hydrogen gas (H2). Its high hydrogen-producing capacity make this bacterium an attractive candidate for microbial biohydrogen production. H...
ORGANISM(S): Caldicellulosiruptor saccharolyticus 
2013-08-28 | E-GEOD-40430 | biostudies-arrayexpress
UnknownBenign descriptors and ADNEX in two-step strategy to estimate risk of malignancy in ovarian tumors: retrospective validation in IOTA5 multicenter cohort.
Not available
S-EPMC10107772 | biostudies-literature
UnknownBiodegradable-Polymer or Durable-Polymer Stents in Patients at High Bleeding Risk: A Randomized, Open-Label Clinical Trial.
Not available
S-EPMC10516164 | biostudies-literature
UnknownRationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY).
Not available
S-EPMC6429932 | biostudies-literature
Sort   by:  
 Page size